Cardioangiologisches Centrum Bethanien
Clinical trials sponsored by Cardioangiologisches Centrum Bethanien, explained in plain language.
-
New catheter aims to improve repeat ablation for AF patients
Disease control Recruiting nowThis study tests a new type of catheter (AFFERA) against a standard one for a repeat heart procedure called ablation in 200 people with symptomatic atrial fibrillation (AF). The goal is to see if the new catheter can better block faulty electrical signals in the heart. Participan…
Phase: NA • Sponsor: Cardioangiologisches Centrum Bethanien • Aim: Disease control
Last updated May 26, 2026 12:13 UTC
-
New heart zap procedure may beat drugs for AF in heart failure patients
Disease control Recruiting nowThis study compares a new procedure called electroporation (using targeted electrical pulses to fix heart rhythm) against standard medications for people with early-stage atrial fibrillation and heart failure. 200 participants will be randomly assigned to either the procedure or …
Phase: NA • Sponsor: Cardioangiologisches Centrum Bethanien • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New balloon device for heart rhythm disorder tested in real-world registry
Knowledge-focused Recruiting nowThis study is a registry that will follow 1000 people with atrial fibrillation who are treated with a new balloon-in-basket device. The goal is to see how well the device works in everyday medical practice and to track any side effects. Participants must be at least 18 years old …
Phase: NA • Sponsor: Cardioangiologisches Centrum Bethanien • Aim: Knowledge-focused
Last updated May 26, 2026 12:01 UTC